Hypophosphataemia is known to induce reversible myocardial dysfunction, but the incidence of hypophosphataemia and its effect on myocardial function during brain death are unknown. In 90 consecutive brain-dead patients, we measured plasma concentrations of phosphate and left ventricular ejection fraction area (LVEFa), using transoesophageal echocardiography. In 15 severely hypophosphataemic ( < 0.40 mmol litre" 1 ), consecutive, brain-dead patients, haemodynamic status, LVEFa, and oxygen delivery and consumption were assessed before and after phosphorus loading (0.30 mmol kg" 1 ). In 10 other brain-dead patients, urine elimination of phosphates was measured. Only 30 (33%) brain-dead patients had normal plasma phosphate concentrations, 22 (24%) had mild hypophosphataemia (0.40-0.80 mmol litre" 1 ) and 38 (42%) had severe hypophosphataemia (< 0.40 mmol litre" 1 ). There were no significant differences in LVEFa between these three groups (mean 53 (SD 16), 55 (12) and 51 (17)%, respectively) and no significant correlation between LVEFa and plasma phosphate concentration (/-= 0.04). In 15 severely hypophosphataemic patients, phosphorus loading increased plasma phosphate concentration from 0.30 (0.10) to 1.06 (0.41) mmol litre" 1 , but did not modify haemodynamic status, LVEFa or oxygen delivery and consumption. In 10 other patients, urine phosphorus elimination was 16.8 (23.3) mmol/ 24 h while plasma phosphate concentration was at its highest level (0.80 (0.37) mmol litre" 1 ), and only one of these patient had a slightly elevated phosphaturia. In conclusion, hypophosphataemia frequently occurs after brain death but has no significant cardiovascular consequences, suggesting that it is related to intracellular transfer and not phosphorus depletion. Consequently, no significant improvement in myocardial function can be expected from phosphorus loading. (Br. J. Anaesth. 1995; 74:424-429) 
Since the development of organ transplantation, it has become more and more important to understand the physiological consequences of brain death on other organ functions. Indeed, appropriate resuscitation of brain-dead organ donors has been shown to be an important prognostic factor in the clinical outcome of cardiac transplantation [1] . Several experimental and clinical studies have suggested that brain death may induce segmental or global myocardial dysfunction [2] [3] [4] . Nevertheless, the mechanisms involved in this myocardial dysfunction have not yet been fully understood, and could be because of: high levels of catecholamines related to the Cushing reflex which appears in the early phase of brain death, leading to direct myocardial injury, coronary vasospasm, or both [5] ; a change from aerobic to anaerobic myocardial metabolism, because of haemodynamic deterioration with low perfusion pressure, which occurs immediately after brain death leading to a stunned myocardium [6] ; a reduction in circulating free triiodothyronine, resulting in a reduction in oxidative metabolism [7] .
Brain death may induce major abnormalities in plasma electrolytes which are mostly related to neuroendocrine modifications, in particular diabetes insipidus [8] . However, few data are available on phosphate concentrations during resuscitation of brain-dead organ donors. Phosphorus is an essential element in cellular biochemical reactions and an important component of cell membranes and structures, and thus maintenance of normal phosphate concentrations is vital for numerous functions: skeletal and respiratory muscle function, haemostasis, red cell integrity and function, and myocardial function [9] . Indeed, experimental [10, 11] and clinical studies [12] have demonstrated that severe hypophosphataemia may induce reversible cardiac failure. Therefore, it is possible that hypophosphataemia may contribute to the myocardial dysfunction observed during brain death.
Thus, we have investigated prospectively braindead patients to determine the incidence of hypo-phosphataemia and the effects of severe hypophosphataemia and its correction on myocardial function.
Patients and methods
After Ethics Committee approval had been obtained, this study was conducted according to French legislation on multiple organ procurement. Brain death was certified by: a neurological examination demonstrating the absence of brainstem reflexes; an apnoea test performed with intratracheal continuous high flow (15 litre min" 1 ) oxygen and after 15 min of mechanical ventilation with an Fi O2 of 100%. The absence of spontaneous respiratory effects after 15 min of apnoea, associated with an arterial Pco 2 exceeding 8 kPa must be demonstrated; no electrical activity during electroencephalographic recording; and absence of hypothermia (< 35 °C) and drugs known to depress the central nervous system.
HYPOPHOSPHATAEMIA IN BRAIN-DEAD PATIENTS
We studied 90 consecutive brain-dead patients. In all patients the following variables were recorded during cardiac assessment using transoesophageal echocardiography: age, sex, duration of mechanical ventilation, time between brain death and cardiac assessment, mean arterial pressure measured via a radial artery cannula, heart rate, fluid load (crystalloids and colloids) since brain death, dose of dopamine administered and body temperature. Desmopressin 1 (ig/2 h was administered in patients with diabetes insipidus, which was diagnosed when urine output exceeded 300 ml h" 1 and urine specific gravity was less than 1003. The following were measured: plasma creatinine, bicarbonate, glucose, calcium, protein and phosphate (normal range 0.80-1.30 mmol litre" 1 ) concentrations (Dimension apparatus, Du Pont de Nemours, Wilmington, DL, USA), arterial pH and Pco 2 (BGElectrolytes, Instrumentation Laboratory, Milano, Italy), and packed cell volume (PCV) (Cobas Argos Apparatus, Roche, Basle Switzerland). These variables are known to influence plasma phosphate concentrations or to be modified by factors known to modify phosphataemia [10] . Brain-dead patients were classified into three groups: normal plasma phosphate concentrations (> 0.80 mmol litre" Transoesophageal echocardiography (HP Sonos 1500, Hewlett-Packard, Andover, MA, USA) was performed by a trained echocardiographist. The short axis view of the left ventricle (LV) at the midpapillary muscle level was recorded on videotape and analysed retrospectively by a blinded observer. LV end-diastolic (LVEDa) and end-systolic (LVESa) areas were traced manually using the light pen system, as reported previously [13] . Three measures of LV areas at three consecutive beats were performed and the mean calculated. The LV ejection fraction area (LVEFa) was calculated from the equation : LVEFa = (LVEDa -LVESa). 100. LVEDa" 1 . LVEFa less than 50 % was considered abnormal.
EFFECTS OF PHOSPHORUS LOADING IN BRAIN-DEAD PATIENTS WITH SEVERE HYPOPHOSPHATAEMIA
We studied 16 brain-dead patients with severe hypophosphataemia (< 0.40 mmol litre" 1 ). Patients with hypovolaemia were excluded, as diagnosed by an LVEDa lower than 5.5 cm 2 irr 2 , as previously reported [14] . Nevertheless, we also excluded patients with a normal LVEDa but virtual obliteration of the left ventricle cavity at end-systole, resulting in a supranormal value for LVEFa (i.e. greater than 75%), which can be considered to reflect mild hypovolaemia. Consequently, 15 patients received i.v. phosphorus loading. Disodium phosphate 0.30 mmol kg" 1 was administered i.v. over a 2-h period, using a motor-driven syringe pump. During the study, all ventilation variables were maintained constant (tidal volume, ventilatory frequency, Fi 02 and end-expiratory pressure), in addition to the infusion rate of dopamine. No colloid was administered and the amount of crystalloid administered was determined according to our resuscitation procedure, that is according to diuresis. Haemodynamic measurements were obtained from a radial artery cannula and a Swan-Ganz catheter (SP5507 S, Viggo-Spectramed, Montigny le Bretonneux, France) connected to a haemodynamic monitor (HP 78354, Hewlett-Packard). Haemodynamic measurements included heart rate, mean arterial pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, right atrial pressure and cardiac output. Cardiac output was measured in triplicate by thermodilution and the mean calculated. From these variables, systemic resistance, total pulmonary resistance, systolic volume and systolic LV work index were calculated, according to standard formulae [15] . Body temperature was monitored using a rectal or oesophageal probe. Arterial and mixed venous blood-gas analysis (BGElectrolytes, Instrumentation Laboratory) was performed and plasma sodium, potassium, bicarbonate, calcium, magnesium, lactate and phosphate concentrations measured (Dimension apparatus, Du Pont de Nemours). PCV was also measured. From bloodgas analysis and haemodynamic measurements, the following variables were calculated: oxygen delivery (£>0 2 ) and consumption (Vo 2 ), tissue oxygen extraction ratio (Vo 2 /Do 2 ) and arteriovenous difference in oxygen content, according to standard formulae [15] .
All biological, haemodynamic and echocardiographic variables were analysed before and after phosphorus loading.
PHOSPHATURIA IN BRAIN-DEAD PATIENTS
In 10 of these brain-dead patients, plasma and urine phosphorus concentrations, and urine output, were measured over several 4-h periods until multiple organ collection. These patients were consecutive patients included at the end of the study. The rate of urinary phosphorus elimination was calculated during each 4-h period (normal range 0-40 mmol/24 h). As plasma phosphorus concentration fluctuated and as the number of 4-h periods differed between patients, two values were noted which corresponded to the highest and lowest plasma phosphate concentrations recorded during the study.
STATISTICAL ANALYSIS
Data are expressed as mean (SD). Comparison of several means was performed using analysis of variance and Newman-Keuls test, or KruskallWallis test for non-Gaussian distribution. Comparison of proportion was performed using the chisquare test with Bonferroni correction. Correlation between two variables and multilinear correlations were performed using the least squares method. The paired Student's t test was used to compare the value before and after phosphorus loading. All P values were two-tailed and P < 0.05 was considered significant. Statistical analysis was performed on a computer using PCSM software (Deltasoft, Meylan, France).
Results

HYPOPHOSPHATAEMIA IN BRAIN-DEAD PATIENTS
We studied 90 brain-dead patients, mean age 37 (range 8-64) yr; 66 (73%) were male. The cause of brain death was head trauma in 56 (62%), cerebrovascular disease in 29 (32%) and cerebral anoxia related to cardiac arrest in five (6%) patients. In these 90 brain-dead patients, only 30 (33%) had normal serum phosphate concentrations (1.07 (0.25) mmol litre" . As shown in table 1, there were no significant differences between these three groups.
In these 90 brain-dead patients, 26 (29%) had a low LVEFa (< 50%). The mean value for LVEFa did not differ significantly between the three groups (table 1). Moreover, there was no significant cor- relation between LVEFa and phosphataemia ( fig. 1 ). Nevertheless, a significant correlation was found between LVEFa and dose of dopamine (r = 0.23, P < 0.03). Multivariate analysis was performed between LVEFa and several variables, including plasma phosphate concentration, and this showed that no significant correlation existed between LVEFa and serum phosphate concentration ( ) were noted, and the dose of dopamine was not modified in any patient.
Phosphorus loading increased plasma phosphate concentration from 0.30 (0.10) to 1.06 (0.41) mmol litre" 1 . No significant changes in the other biological variables were noted, except a small but significant increase in plasma sodium concentration (table 3) . Phosphorus loading did not significantly modify haemodynamic variables (table 4) . Blood-gas variables, oxygen delivery and consumption, and the arteriovenous content difference in oxygen remained unchanged after phosphorus loading (table 5).
LVEFa was less than 50% in nine patients and thus these were considered as having a low LVEFa. Phosphorus loading did not significantly modify LVEDa (18.0 (4.5) vs 18.3 (5.5) cm 2 ) or LVESa (12.1 (6.9) vs 12.3 (7.9) cm 2 ). Consequently, phosphorus loading did not significantly modify LVEFa (41 (20) vs 41 (18)%), even in the nine patients who had a low LVEFa (fig. 2) . In eight of these 15 patients, transoesophageal echocardiography was performed again just before organ collection and 4 (2) h after phosphorus loading, while plasma phosphate concentration was 0.60 (0.38) mmol litre" 1 . In these eight patients, LVEFa was not significantly modified (43 (18) %) compared with the values obtained before (41 (16)%) and immediately after (41 (18)%) phosphorus loading ( fig. 2 ).
PHOSPHATURIA IN BRAIN-DEAD PATIENTS
We studied 10 consecutive brain-dead patients, mean age 38 (range 8-61) yr, seven male and three female. The cause of brain death was head trauma in five and cerebrovascular disease in five patients. These patients were studied during 3 (1) periods of 4h 
Discussion
We observed that hypophosphataemia occurred in 66 % and was severe in 42 % of brain-dead patients. However, we did not observe any significant differences between brain-dead patients with or without hypophosphataemia (table 1) , and in 15 severely hypophosphataemic brain-dead patients, phosphorus loading did not significantly modify haemodynamic state (table 4) , left ventricular function ( fig.  2 ) or oxygen delivery and consumption (table 5) .
The major causes of hypophosphataemia are inadequate phosphorus intake, impaired absorption, excess urinary excretion and intracellular transfer [9] . However, only urinary excretion and intracellular transfer are responsible for acute hypophosphataemia [16] . In the present study, we observed that urinary loss of phosphorus was not increased and thus could not explain the dramatic and rapid decrease in plasma phosphate concentration observed in these patients. Moreover, the lack of significant differences in LVEFa between braindead patients with or without hypophosphataemia (table 1) and the absence of significant changes in haemodynamic variables after phosphorus loading (table 4, fig. 2 ) suggest that the mechanism of hypophosphataemia was intracellular transfer without a significant decrease in intracellular phosphate stores. Many factors can induce intracellular shift of phosphates, including respiratory alkalosis [17] , catecholamine administration [18] and hyperglycaemia, all of which are present during brain death resuscitation. We failed to identify precisely the British Journal of Anaesthesia important factors associated with hypophosphataemia, as shown in table 1. Nevertheless, as the plasma concentration of phosphate appears to decrease with time after brain death, all of these factors, and others, such as volume expansion [19] , are potential candidates.
The cardiovascular consequences of severe hypophosphataemia have been demonstrated clearly in experimental [10, 11] and clinical studies [12] . Hypophosphataemia induces a reduction in ATP, creatine phosphokinase and inorganic phosphate in the myocardium, leading to a decrease in contractility and reduced response to adrenaline [10, 11] . O'Connor, Wheeler and Bethune [12] reported that correction of severe hypophosphataemia results in a dramatic improvement in cardiac function in humans. Such improvement in contractility has also been demonstrated for the diaphragm in humans [20] . In the present study, we did not observe any significant difference in LVEFa between brain-dead patients with or without hypophosphataemia ( 2 ). The lack of changes in LVEFa is important as, apart from the fact that LVEFa is dependent on both preload and afterload, it is considered to be an efficient measure of ventricular function. Moreover, as there were no significant changes in haemodynamic variables indicating lack of significant modification in both preload and afterload, our results suggest that myocardial contractility remained unchanged during phosphorus loading [21] . Therefore, our results indicate that severe hypophosphataemia in brain-dead patients induced no significant cardiovascular consequences, and that the intramyocardial stores of phosphates were therefore not decreased.
A significant increase in plasma sodium concentration was observed (table 3) , related to the administration of sodium phosphate. Nevertheless, the increase in plasma sodium concentrations was probably too small and too slow to induce any significant haemodynamic change, such as those reported previously with rapid infusion of hypertonic sodium [22] . No other significant changes in biochemical variables were observed during phosphorus loading. This is important as serious hazards have been reported after rapid i.v. administration of phosphates in patients with diabetic ketoacidosis, including hypocalcaemia and hypomagnesaemia [23] . In the present study, despite the administration of a large dose (0.30 mmol kg" 1 ) within a short period (2 h), no significant changes in plasma calcium or magnesium concentrations were noted (table 3) . This is noteworthy because there is not usually enough time before organ retrieval to allow slower administration.
Phosphorus plays an important role in red blood cells, acting on the oxyhaemoglobin dissociation curve [24, 25] , and may thus impair oxygen delivery to the tissues. Moreover, in red blood cells, phosphate concentration is controlled only by passive diffusion, so that any reduction in plasma phosphate concentration (related to phosphate depletion or intracellular transfer) induces a reduction in red blood cell phosphate concentration. In the present study, phosphorus loading did not modify oxygen delivery and consumption (table 5) . Nevertheless, it should be noted that: (1) brain-dead patients had high oxygen delivery and low oxygen consumption, resulting in a low arteriovenous difference in oxygen content [26, 27] ; consequently, changes in oxygen delivery to the tissues may not have been sufficient to significantly modify oxygen consumption; (2) oxygen consumption was not measured but calculated using cardiac output and arteriovenous difference in oxygen content values; this method is considered to be less accurate than the direct measure, and thus small changes in oxygen consumption might have been overlooked. A decrease in oxygen delivery to the tissues may be crucial in brain-dead patients with a low cardiac output because of myocardial dysfunction and those with a low oxygen transport because of hypoxaemia [26, 27] . Indeed, Mateo and colleagues [26] have shown that oxygen consumption depends on oxygen delivery in some brain-dead patients, and that this is associated with increased blood lactate concentrations. Thus, further studies are required to determine precisely the consequences of correction of hypophosphataemia on oxygen delivery and consumption in brain-dead patients, especially those with oxygen delivery dependence.
